Vitarka Therapeutics Ltd, the EndoPore® cancer therapeutics company, today announced the appointment of Dr John Beadle as the new Chairman of the Board.
Dr Vineeta Tripathi, Chief Executive and Chief Scientific Officer, Vitarka Therapeutics talks about the valuable lessons learnt, through her participation in a life sciences development programme, to accelerate her biotech start-up providing novel therapeutics for cancer indications.
